AstraZeneca: Preparing for future pandemics in UK

AstraZeneca: EMA validates Dato-DXd for two cancers

AstraZeneca: $5 billion bond issue

AstraZeneca: Successfully completes the acquisition of Icosavax

AstraZeneca: ‘major breakthrough’ in lung cancer